Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
Fly Intel: Top five analyst downgrades » 10:05
07/08/20
07/08
10:05
07/08/20
10:05
MO

Altria Group

$40.42 /

+0.47 (+1.18%)

, VSTO

Vista Outdoor

$15.20 /

-0.07 (-0.46%)

, HUBS

HubSpot

$232.50 /

-2.535 (-1.08%)

, BAH

Booz Allen

$75.00 /

-0.45 (-0.60%)

, CACI

CACI

$202.99 /

-1.97 (-0.96%)

, NVAX

Novavax

$100.31 /

-4.25 (-4.06%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Altria Group (MO) downgraded to Equal Weight from Overweight at Barclays with analyst Gaurav Jain saying the company is 100% U.S.-exposed and continues to lose market share. 2. Vista Outdoor (VSTO) downgraded to Neutral from Buy at B. Riley FBR with analyst Eric Wold saying the shares have increased by 115% over the past two months. 3. HubSpot (HUBS) downgraded to Neutral from Buy at Mizuho with analyst Siti Panigrahi saying the company has responded to small- and mid-sized businesses being hit hard by COVID-19 with discounts, downgrades, and large promotions. 4. Booz Allen (BAH) and CACI (CACI) were downgraded to Market Perform from Outperform at Raymond James. 5. Novavax (NVAX) downgraded to Neutral from Buy at Ladenburg with analyst Michael Higgins citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
VSTO Vista Outdoor
$15.20 /

-0.07 (-0.46%)

NVAX Novavax
$100.31 /

-4.25 (-4.06%)

MO Altria Group
$40.42 /

+0.47 (+1.18%)

CACI CACI
$202.99 /

-1.97 (-0.96%)

BAH Booz Allen
$75.00 /

-0.45 (-0.60%)

MO Altria Group
$40.42 /

+0.47 (+1.18%)

07/08/20 Barclays
Altria downgraded to Equal Weight on share losses at Barclays
07/08/20 Barclays
Altria Group downgraded to Equal Weight from Overweight at Barclays
07/07/20 Stifel
IQOS reduced exposure claim a 'win' for Philip Morris, Altria, says Stifel
04/20/20 Deutsche Bank
Altria Group price target lowered to $51 from $56 at Deutsche Bank
VSTO Vista Outdoor
$15.20 /

-0.07 (-0.46%)

07/08/20 B. Riley FBR
Vista Outdoor downgraded to Neutral after 115% rally at B. Riley FBR
07/08/20 B. Riley FBR
Vista Outdoor downgraded to Neutral from Buy at B. Riley FBR
07/07/20 Lake Street
Vista Outdoor price target raised to $18 from $13 at Lake Street
06/25/20 Monness Crespi
Vista Outdoor price target raised to $15 from $12 at Monness Crespi
HUBS HubSpot
$232.50 /

-2.535 (-1.08%)

07/08/20 Mizuho
HubSpot downgraded to Neutral on near-term headwinds at Mizuho
07/08/20 Mizuho
HubSpot downgraded to Neutral from Buy at Mizuho
06/29/20 Goldman Sachs
HubSpot price target raised to $263 from $184 at Goldman Sachs
05/07/20 Raymond James
HubSpot price target raised to $190 from $175 at Raymond James
BAH Booz Allen
$75.00 /

-0.45 (-0.60%)

07/08/20 Raymond James
Booz Allen downgraded to Market Perform from Outperform at Raymond James
07/08/20 Raymond James
Booz Allen downgraded to Market Perform from Outperform at Raymond James
06/29/20 William Blair
William Blair says Booz Allen looks to have renewed 2020's biggest expiring deal
06/05/20 William Blair
William Blair back Outperform on Booz Allen after USAF research lab task order
CACI CACI
$202.99 /

-1.97 (-0.96%)

07/08/20 Raymond James
CACI downgraded to Market Perform from Outperform at Raymond James
07/08/20 Raymond James
CACI downgraded to Market Perform from Outperform at Raymond James
06/12/20 William Blair
William Blair sees near-term takeover of Perspecta as unlikely despite Jana news
05/04/20 Wells Fargo
Leidos price target raised to $114 from $105 at Wells Fargo
NVAX Novavax
$100.31 /

-4.25 (-4.06%)

07/08/20 Ladenburg
Novavax downgraded to Neutral from Buy at Ladenburg
07/07/20 Cantor Fitzgerald
Novavax price target raised to $148 from $88 at Cantor Fitzgerald
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
06/29/20 B. Riley FBR
Novavax price target raised to $106 from $74 at B. Riley FBR
VSTO Vista Outdoor
$15.20 /

-0.07 (-0.46%)

NVAX Novavax
$100.31 /

-4.25 (-4.06%)

MO Altria Group
$40.42 /

+0.47 (+1.18%)

HUBS HubSpot
$232.50 /

-2.535 (-1.08%)

CACI CACI
$202.99 /

-1.97 (-0.96%)

BAH Booz Allen
$75.00 /

-0.45 (-0.60%)

VSTO Vista Outdoor
$15.20 /

-0.07 (-0.46%)

NVAX Novavax
$100.31 /

-4.25 (-4.06%)

MO Altria Group
$40.42 /

+0.47 (+1.18%)

CACI CACI
$202.99 /

-1.97 (-0.96%)

VSTO Vista Outdoor
$15.20 /

-0.07 (-0.46%)

NVAX Novavax
$100.31 /

-4.25 (-4.06%)

MO Altria Group
$40.42 /

+0.47 (+1.18%)

HUBS HubSpot
$232.50 /

-2.535 (-1.08%)

CACI CACI
$202.99 /

-1.97 (-0.96%)

BAH Booz Allen
$75.00 /

-0.45 (-0.60%)

NVAX Novavax
$100.31 /

-4.25 (-4.06%)

MO Altria Group
$40.42 /

+0.47 (+1.18%)

Downgrade
Booz Allen downgraded to Market Perform from Outperform at Raymond James » 07:19
07/08/20
07/08
07:19
07/08/20
07:19
BAH

Booz Allen

$75.45 /

-1.955 (-2.53%)

Raymond James analyst…

Raymond James analyst Brian Gesuale downgraded Booz Allen to Market Perform from Outperform without a price target. While he remains comfortable with expectations and business momentum in the near-term, Gesuale says the downgrade reflects decelerating fundamentals in the intermediate term and potentially meaningful re-rating of defense centric service stocks lower from near historically high valuations. . The re-rate could begin to occur as investors contemplate potential political changes, slowing industry growth, and changing corporate tax laws, the analyst tells investors in a research note.

ShowHide Related Items >><<
BAH Booz Allen
$75.45 /

-1.955 (-2.53%)

BAH Booz Allen
$75.45 /

-1.955 (-2.53%)

07/08/20 Raymond James
Booz Allen downgraded to Market Perform from Outperform at Raymond James
06/29/20 William Blair
William Blair says Booz Allen looks to have renewed 2020's biggest expiring deal
06/05/20 William Blair
William Blair back Outperform on Booz Allen after USAF research lab task order
05/19/20 Wells Fargo
Booz Allen price target raised to $82 from $77 at Wells Fargo
BAH Booz Allen
$75.45 /

-1.955 (-2.53%)

BAH Booz Allen
$75.45 /

-1.955 (-2.53%)

Downgrade
Booz Allen downgraded to Market Perform from Outperform at Raymond James » 05:19
07/08/20
07/08
05:19
07/08/20
05:19
BAH

Booz Allen

$75.45 /

-1.955 (-2.53%)

Raymond James analyst…

Raymond James analyst Brian Gesuale downgraded Booz Allen to Market Perform from Outperform.

ShowHide Related Items >><<
BAH Booz Allen
$75.45 /

-1.955 (-2.53%)

BAH Booz Allen
$75.45 /

-1.955 (-2.53%)

06/29/20 William Blair
William Blair says Booz Allen looks to have renewed 2020's biggest expiring deal
06/05/20 William Blair
William Blair back Outperform on Booz Allen after USAF research lab task order
05/19/20 Wells Fargo
Booz Allen price target raised to $82 from $77 at Wells Fargo
04/20/20
Fly Intel: Top five analyst downgrades
BAH Booz Allen
$75.45 /

-1.955 (-2.53%)

BAH Booz Allen
$75.45 /

-1.955 (-2.53%)

Over a week ago
Hot Stocks
Accenture, CAE and others awarded $950M ceiling Air Force contract » 17:23
07/01/20
07/01
17:23
07/01/20
17:23
ACN

Accenture

$214.39 /

-0.29 (-0.14%)

, CAE

CAE

$15.63 /

-0.57 (-3.52%)

, LDOS

Leidos

$93.34 /

-0.39 (-0.42%)

, MRCY

Mercury Systems

$81.26 /

+2.69 (+3.42%)

, SAIC

SAIC

$77.15 /

-0.74 (-0.95%)

, NTCT

NetScout

$25.47 /

-0.13 (-0.51%)

, BAH

Booz Allen

$79.47 /

+1.62 (+2.08%)

Accenture (ACN), CAE…

Accenture (ACN), CAE (CAE), Leidos (LDOS), Mercury Systems (MRCY), SAIC (SAIC), Booz Allen Hamilton (BAH) and NetScout (NTCT), have been awarded $950M ceiling indefinite-delivery/indefinite-quantity contracts to compete for future efforts associated with the maturation, demonstration and proliferation of capability across platforms and domains, leveraging open systems design, modern software and algorithm development in order to enable joint all domain command and control. These contracts provide for the development and operation of systems as a unified force across all domains in an open architecture family of systems that enables capabilities via multiple integrated platforms. The locations of performance are to be determined at the contract direct order level and are expected to be completed May 28, 2025. These awards are the result of competition. FY20 research, development, test and evaluation funds will fully fund initial delivery orders. Air Force Life Cycle Management is the contracting activity.

ShowHide Related Items >><<
SAIC SAIC
$77.15 /

-0.74 (-0.95%)

NTCT NetScout
$25.47 /

-0.13 (-0.51%)

MRCY Mercury Systems
$81.26 /

+2.69 (+3.42%)

LDOS Leidos
$93.34 /

-0.39 (-0.42%)

CAE CAE
$15.63 /

-0.57 (-3.52%)

BAH Booz Allen
$79.47 /

+1.62 (+2.08%)

ACN Accenture
$214.39 /

-0.29 (-0.14%)

ACN Accenture
$214.39 /

-0.29 (-0.14%)

06/26/20 Susquehanna
Accenture price target raised to $250 from $225 at Susquehanna
06/26/20 BMO Capital
Accenture price target raised to $215 from $188 at BMO Capital
06/26/20 Deutsche Bank
Accenture price target raised to $245 from $215 at Deutsche Bank
06/26/20 Citi
Accenture price target raised to $247 from $230 at Citi
CAE CAE
$15.63 /

-0.57 (-3.52%)

07/01/20
CAE downgraded to Neutral from Buy at BofA
07/01/20 BofA
CAE downgraded to Neutral from Buy at BofA
06/19/20 BMO Capital
CAE price target raised to C$23 from C$20 at BMO Capital
06/18/20 CIBC
CAE price target raised to C$27 from C$24 at CIBC
LDOS Leidos
$93.34 /

-0.39 (-0.42%)

06/11/20
Fly Intel: Top five analyst initiations
06/11/20 Baird
Baird starts Leidos at Outperform, sees growth poised to ramp next year
06/10/20 Baird
Leidos initiated with an Outperform at Baird
05/07/20
Fly Intel: Top five analyst initiations
MRCY Mercury Systems
$81.26 /

+2.69 (+3.42%)

05/21/20
Fly Intel: Top five analyst initiations
05/20/20 RBC Capital
Mercury Systems initiated with Sector Perform on valuation at RBC Capital
05/20/20 RBC Capital
Mercury Systems initiated with a Sector Perform at RBC Capital
04/29/20 Baird
Mercury Systems price target raised to $100 from $87 at Baird
SAIC SAIC
$77.15 /

-0.74 (-0.95%)

06/12/20 William Blair
William Blair sees near-term takeover of Perspecta as unlikely despite Jana news
05/19/20 Wells Fargo
SAIC price target raised to $105 from $85 at Wells Fargo
04/20/20
Fly Intel: Top five analyst upgrades
04/20/20 Goldman Sachs
Booz Allen downgraded to Neutral from Buy at Goldman Sachs
NTCT NetScout
$25.47 /

-0.13 (-0.51%)

04/17/20 Lake Street
NetScout price target lowered to $28 from $33 at Lake Street
02/21/20 Lake Street
NetScout's recent positive trends continue, says Lake Street
01/30/20 Lake Street
NetScout price target raised to $33 from $32 at Lake Street
01/15/20 Piper Sandler
Piper introduces long VMware, short Juniper pair trade into Q4 results
BAH Booz Allen
$79.47 /

+1.62 (+2.08%)

06/29/20 William Blair
William Blair says Booz Allen looks to have renewed 2020's biggest expiring deal
06/05/20 William Blair
William Blair back Outperform on Booz Allen after USAF research lab task order
05/19/20 Wells Fargo
Booz Allen price target raised to $82 from $77 at Wells Fargo
04/20/20
Fly Intel: Top five analyst downgrades
SAIC SAIC
$77.15 /

-0.74 (-0.95%)

NTCT NetScout
$25.47 /

-0.13 (-0.51%)

MRCY Mercury Systems
$81.26 /

+2.69 (+3.42%)

LDOS Leidos
$93.34 /

-0.39 (-0.42%)

CAE CAE
$15.63 /

-0.57 (-3.52%)

BAH Booz Allen
$79.47 /

+1.62 (+2.08%)

ACN Accenture
$214.39 /

-0.29 (-0.14%)

  • 16
    Jan
LDOS Leidos
$93.34 /

-0.39 (-0.42%)

ACN Accenture
$214.39 /

-0.29 (-0.14%)

SAIC SAIC
$77.15 /

-0.74 (-0.95%)

MRCY Mercury Systems
$81.26 /

+2.69 (+3.42%)

LDOS Leidos
$93.34 /

-0.39 (-0.42%)

BAH Booz Allen
$79.47 /

+1.62 (+2.08%)

ACN Accenture
$214.39 /

-0.29 (-0.14%)

ACN Accenture
$214.39 /

-0.29 (-0.14%)

Recommendations
William Blair says Booz Allen looks to have renewed 2020's biggest expiring deal » 09:49
06/29/20
06/29
09:49
06/29/20
09:49
BAH

Booz Allen

$74.84 /

+0.59 (+0.79%)

William Blair analyst…

William Blair analyst Louie DiPalma, citing data from the federal contracts database, said that it appears that Booz Allen secured renewal for its $937M Army threat mitigation contract that was set to end in this September. He believes this was Booz Allen's largest recompete for this year and its fourth-largest task order overall, the analyst tells investors. Winning this recompete removes a significant overhang for Booz Allen, whose management indicated that this year has a greater than normal amount of recompete deals, added DiPalma, who keeps an Outperform rating on the stock.

ShowHide Related Items >><<
BAH Booz Allen
$74.84 /

+0.59 (+0.79%)

BAH Booz Allen
$74.84 /

+0.59 (+0.79%)

06/05/20 William Blair
William Blair back Outperform on Booz Allen after USAF research lab task order
05/19/20 Wells Fargo
Booz Allen price target raised to $82 from $77 at Wells Fargo
04/20/20
Fly Intel: Top five analyst downgrades
04/20/20 Citi
Booz Allen upgraded to Buy from Neutral at Citi
BAH Booz Allen
$74.84 /

+0.59 (+0.79%)

BAH Booz Allen
$74.84 /

+0.59 (+0.79%)

Hot Stocks
Accenture, Booz Allen awarded on maximum $990M Air Force contract » 17:24
06/17/20
06/17
17:24
06/17/20
17:24
ACN

Accenture

$205.29 /

+1.1 (+0.54%)

, BAH

Booz Allen

$79.47 /

+1.465 (+1.88%)

Accenture (ACN), Booz…

Accenture (ACN), Booz Allen (BAH) and others have been awarded a ceiling $990M multiple-award, indefinite-delivery/indefinite-quantity, firm-fixed-price contract to provide advisory and assistance services to support the Deputy Assistant Secretary of the Air Force Office of Business Transformation and deputy chief management officer in managing and improving strategic transformation initiatives at the enterprise level. Work will be performed at various locations and is expected to be completed June 16, 2027. This award is the result of a competitive acquisition and seven offers were received. FY20 operations and maintenance funds in the amount of $500 for each contract are being obligated at the time of award. Air Force District of Washington is the contracting activity.

ShowHide Related Items >><<
BAH Booz Allen
$79.47 /

+1.465 (+1.88%)

ACN Accenture
$205.29 /

+1.1 (+0.54%)

ACN Accenture
$205.29 /

+1.1 (+0.54%)

06/17/20 Citi
Accenture price target raised to $230 from $188 at Citi
06/03/20 Exane BNP Paribas
Accenture downgraded to Neutral from Outperform at Exane BNP Paribas
05/22/20 Piper Sandler
Piper expands Software coverage, favors companies that drive automation
05/21/20 Piper Sandler
Accenture initiated with a Neutral at Piper Sandler
BAH Booz Allen
$79.47 /

+1.465 (+1.88%)

06/05/20 William Blair
William Blair back Outperform on Booz Allen after USAF research lab task order
05/19/20 Wells Fargo
Booz Allen price target raised to $82 from $77 at Wells Fargo
04/20/20
Fly Intel: Top five analyst downgrades
04/20/20 Citi
Booz Allen upgraded to Buy from Neutral at Citi
BAH Booz Allen
$79.47 /

+1.465 (+1.88%)

ACN Accenture
$205.29 /

+1.1 (+0.54%)

ACN Accenture
$205.29 /

+1.1 (+0.54%)

BAH Booz Allen
$79.47 /

+1.465 (+1.88%)

ACN Accenture
$205.29 /

+1.1 (+0.54%)

ACN Accenture
$205.29 /

+1.1 (+0.54%)

Over a month ago
Recommendations
William Blair back Outperform on Booz Allen after USAF research lab task order » 15:46
06/05/20
06/05
15:46
06/05/20
15:46
BAH

Booz Allen

$80.66 /

+0.04 (+0.05%)

William Blair analyst…

William Blair analyst Louie DiPalma reiterated an Outperform rating after Booz Allen on June 3 won a $559M, five-year task order to provide specialized IT engineering services within the ISR domain for the Air Force Research Laboratory's Information Directorate, which prototypes next-generation technologies. The analyst noted that the company discussed on its Q4 earnings call how it is pursuing larger awards than in the past, and that the latest from the Air Force is the company's 16th-largest contract/task order by potential dollar amount. DiPalma added that he is under the impression that the task order bundles new work and existing services.

ShowHide Related Items >><<
BAH Booz Allen
$80.66 /

+0.04 (+0.05%)

BAH Booz Allen
$80.66 /

+0.04 (+0.05%)

05/19/20 Wells Fargo
Booz Allen price target raised to $82 from $77 at Wells Fargo
04/20/20
Fly Intel: Top five analyst downgrades
04/20/20 Citi
Booz Allen upgraded to Buy from Neutral at Citi
04/20/20 Goldman Sachs
Booz Allen downgraded to Neutral from Buy at Goldman Sachs
BAH Booz Allen
$80.66 /

+0.04 (+0.05%)

BAH Booz Allen
$80.66 /

+0.04 (+0.05%)

On The Fly
Fly Intel: Pre-market Movers » 09:06
05/26/20
05/26
09:06
05/26/20
09:06
SNY

Sanofi

$47.31 /

-0.18 (-0.38%)

, NVAX

Novavax

$46.14 /

-3.975 (-7.93%)

, MRK

Merck

$76.37 /

-0.17 (-0.22%)

, ARGX

Argenx

$158.26 /

+2.26 (+1.45%)

, HIBB

Hibbett Sports

$19.55 /

+0.57 (+3.00%)

, AMWD

American Woodmark

$60.55 /

+1.345 (+2.27%)

, BAH

Booz Allen

$75.71 /

+0.78 (+1.04%)

, MGIC

Magic Software

$10.05 /

-0.01 (-0.10%)

, PLAN

Anaplan

$51.07 /

+2.12 (+4.33%)

, ONEM

1Life Healthcare

$38.00 /

+0.09 (+0.24%)

, HTZ

Hertz

$2.84 /

-0.215 (-7.04%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

ONEM 1Life Healthcare
$38.00 /

+0.09 (+0.24%)

NVAX Novavax
$46.14 /

-3.975 (-7.93%)

MRK Merck
$76.37 /

-0.17 (-0.22%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

HIBB Hibbett Sports
$19.55 /

+0.57 (+3.00%)

BAH Booz Allen
$75.71 /

+0.78 (+1.04%)

ARGX Argenx
$158.26 /

+2.26 (+1.45%)

AMWD American Woodmark
$60.55 /

+1.345 (+2.27%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

05/26/20 SVB Leerink
Sanofi overhang removed, Regeneron capital structure improving, says SVB Leerink
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
05/06/20 Oppenheimer
Regeneron price target raised to $625 from $525 at Oppenheimer
04/30/20 Roth Capital
aTyr Pharma '1923 another 'shot on goal' in COVID-19 fight, says Roth Capital
NVAX Novavax
$46.14 /

-3.975 (-7.93%)

05/26/20 B. Riley FBR
Novavax has become a leading COVID vaccine candidate, says B. Riley FBR
05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
05/14/20 Ladenburg
Novavax price target raised to $50 from $38 at Ladenburg
05/12/20 B. Riley FBR
Novavax price target raised to $43 from $29 at B. Riley FBR
MRK Merck
$76.37 /

-0.17 (-0.22%)

05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
04/27/20 SVB Leerink
Clovis downgraded to Underperform at SVB Leerink as prostate opportunity fades
04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
03/23/20 Mizuho
Merck business disruptions have been modest, says Mizuho
ARGX Argenx
$158.26 /

+2.26 (+1.45%)

05/26/20 Stifel
Argenx's results in MG should read through positively for Momenta, says Stifel
05/26/20 Piper Sandler
Argenx price target raised to $258 from $198 at Piper Sandler
05/26/20 Stifel
Argenx should trade up to 'mid-$180 range' after trial success, says Stifel
05/21/20 Credit Suisse
Argenx price target raised to $160 from $150 at Credit Suisse
HIBB Hibbett Sports
$19.55 /

+0.57 (+3.00%)

05/26/20 Baird
Hibbett Sports Q1 comps better than feared, says Baird
03/23/20 Susquehanna
Hibbett Sports not closing stores, Susquehanna downgrades to Neutral
03/23/20 Susquehanna
Hibbett Sports downgraded to Neutral from Positive at Susquehanna
03/20/20 Baird
Hibbett Sports price target lowered to $15 from $32 at Baird
AMWD American Woodmark
$60.55 /

+1.345 (+2.27%)

04/16/20 Baird
American Woodmark downgraded to Neutral at Baird
04/16/20 Baird
American Woodmark downgraded to Neutral from Outperform at Baird
03/03/20 Sidoti
American Woodmark upgraded to Buy from Neutral at Sidoti
01/24/20 Loop Capital
American Woodmark initiated with a Hold at Loop Capital
BAH Booz Allen
$75.71 /

+0.78 (+1.04%)

05/19/20 Wells Fargo
Booz Allen price target raised to $82 from $77 at Wells Fargo
04/20/20
Fly Intel: Top five analyst downgrades
04/20/20 Citi
Booz Allen upgraded to Buy from Neutral at Citi
04/20/20 Goldman Sachs
Booz Allen downgraded to Neutral from Buy at Goldman Sachs
MGIC Magic Software
$10.05 /

-0.01 (-0.10%)

03/26/20 MKM Partners
MKM Partners sees Mortgage Insurers as attractively valued
03/11/20
Fly Intel: Top five analyst downgrades
03/11/20 H.C. Wainwright
Magic Software downgraded to Neutral from Buy at H.C. Wainwright
11/15/19 H.C. Wainwright
Magic Software price target raised to $11 from $10 at H.C. Wainwright
PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

05/21/20 RBC Capital
Anaplan price target raised to $55 from $51 at RBC Capital
05/20/20 Mizuho
Mizuho boosts Anaplan target to $50, makes top pick into Software earnings
05/20/20 Wells Fargo
Wells Fargo downgrades Anaplan on 'more difficult near-term setup'
05/20/20 Wells Fargo
Anaplan downgraded to Equal Weight from Overweight at Wells Fargo
ONEM 1Life Healthcare
$38.00 /

+0.09 (+0.24%)

05/14/20 SunTrust
1Life Healthcare price target raised to $30 from $26 at SunTrust
05/14/20 Wells Fargo
1Life Healthcare price target raised to $23 from $18 at Wells Fargo
05/14/20 Piper Sandler
1Life Healthcare price target raised to $29 from $27 at Piper Sandler
02/25/20 Morgan Stanley
1Life Healthcare initiated with an Overweight at Morgan Stanley
HTZ Hertz
$2.84 /

-0.215 (-7.04%)

05/05/20 Morgan Stanley
2020 may not be quite as bad as feared for used cars, says Morgan Stanley
04/27/20
Fly Intel: Top five analyst downgrades
04/27/20 Barclays
Barclays downgrades Hertz to Underweight on risk of capital call
04/27/20 Barclays
Hertz downgraded to Underweight from Equal Weight at Barclays
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

ONEM 1Life Healthcare
$38.00 /

+0.09 (+0.24%)

NVAX Novavax
$46.14 /

-3.975 (-7.93%)

MRK Merck
$76.37 /

-0.17 (-0.22%)

MGIC Magic Software
$10.05 /

-0.01 (-0.10%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

HIBB Hibbett Sports
$19.55 /

+0.57 (+3.00%)

BAH Booz Allen
$75.71 /

+0.78 (+1.04%)

AMWD American Woodmark
$60.55 /

+1.345 (+2.27%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

NVAX Novavax
$46.14 /

-3.975 (-7.93%)

MRK Merck
$76.37 /

-0.17 (-0.22%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

HIBB Hibbett Sports
$19.55 /

+0.57 (+3.00%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

ONEM 1Life Healthcare
$38.00 /

+0.09 (+0.24%)

NVAX Novavax
$46.14 /

-3.975 (-7.93%)

MRK Merck
$76.37 /

-0.17 (-0.22%)

MGIC Magic Software
$10.05 /

-0.01 (-0.10%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

HIBB Hibbett Sports
$19.55 /

+0.57 (+3.00%)

ARGX Argenx
$158.26 /

+2.26 (+1.45%)

AMWD American Woodmark
$60.55 /

+1.345 (+2.27%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

ONEM 1Life Healthcare
$38.00 /

+0.09 (+0.24%)

NVAX Novavax
$46.14 /

-3.975 (-7.93%)

MRK Merck
$76.37 /

-0.17 (-0.22%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

Earnings
Booz Allen reports Q4 adjusted EPS 73c, consensus 69c  06:50
05/26/20
05/26
06:50
05/26/20
06:50
BAH

Booz Allen

$75.71 /

+0.78 (+1.04%)

 
ShowHide Related Items >><<
BAH Booz Allen
$75.71 /

+0.78 (+1.04%)

BAH Booz Allen
$75.71 /

+0.78 (+1.04%)

05/19/20 Wells Fargo
Booz Allen price target raised to $82 from $77 at Wells Fargo
04/20/20
Fly Intel: Top five analyst downgrades
04/20/20 Citi
Booz Allen upgraded to Buy from Neutral at Citi
04/20/20 Goldman Sachs
Booz Allen downgraded to Neutral from Buy at Goldman Sachs
BAH Booz Allen
$75.71 /

+0.78 (+1.04%)

Hot Stocks
Booz Allen sees FY21 cash from operating activities $550M-$600M  06:49
05/26/20
05/26
06:49
05/26/20
06:49
BAH

Booz Allen

$75.71 /

+0.78 (+1.04%)

 
ShowHide Related Items >><<
BAH Booz Allen
$75.71 /

+0.78 (+1.04%)

BAH Booz Allen
$75.71 /

+0.78 (+1.04%)

05/19/20 Wells Fargo
Booz Allen price target raised to $82 from $77 at Wells Fargo
04/20/20
Fly Intel: Top five analyst downgrades
04/20/20 Citi
Booz Allen upgraded to Buy from Neutral at Citi
04/20/20 Goldman Sachs
Booz Allen downgraded to Neutral from Buy at Goldman Sachs
BAH Booz Allen
$75.71 /

+0.78 (+1.04%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.